In addition, it has been suggested that adding endostatin to current chemotherapeutic strategies may enhance the efficacy of the treatment for carcinoid and pancreatic neuroendocrine tumors [176]. The gene discussed is COL18A1; the disease is pancreatic neuroendocrine tumor.